

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to muramyl dipeptide (GO:0032495) | 5.35755379 |
| 2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.66796015 |
| 3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.66796015 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 4.66796015 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.66796015 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.66796015 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.66796015 |
| 8 | response to peptidoglycan (GO:0032494) | 4.35565859 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.20943590 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.07479683 |
| 11 | positive regulation of heat generation (GO:0031652) | 4.04117309 |
| 12 | regulation of chronic inflammatory response (GO:0002676) | 4.03142068 |
| 13 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.01663657 |
| 14 | NIK/NF-kappaB signaling (GO:0038061) | 4.00570877 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.94811115 |
| 16 | cellular extravasation (GO:0045123) | 3.89831779 |
| 17 | regulation of fever generation (GO:0031620) | 3.80738400 |
| 18 | macrophage activation involved in immune response (GO:0002281) | 3.76418990 |
| 19 | microglial cell activation (GO:0001774) | 3.72364812 |
| 20 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.65337728 |
| 21 | tolerance induction (GO:0002507) | 3.64903165 |
| 22 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.61826335 |
| 23 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.44823216 |
| 24 | regulation of interferon-alpha production (GO:0032647) | 3.40492096 |
| 25 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.38244623 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 3.36089867 |
| 27 | germinal center formation (GO:0002467) | 3.36023264 |
| 28 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.35679885 |
| 29 | detection of other organism (GO:0098543) | 3.35342796 |
| 30 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.33373565 |
| 31 | leukocyte aggregation (GO:0070486) | 3.31365432 |
| 32 | positive regulation of interferon-alpha production (GO:0032727) | 3.29268413 |
| 33 | negative regulation of interleukin-12 production (GO:0032695) | 3.26867637 |
| 34 | positive regulation of interleukin-12 production (GO:0032735) | 3.25244217 |
| 35 | negative regulation of lipid storage (GO:0010888) | 3.23747866 |
| 36 | granulocyte activation (GO:0036230) | 3.22332436 |
| 37 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.18294043 |
| 38 | neutrophil activation (GO:0042119) | 3.17978271 |
| 39 | modulation by symbiont of host cellular process (GO:0044068) | 3.15383469 |
| 40 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.15365601 |
| 41 | cytokine secretion (GO:0050663) | 3.14500735 |
| 42 | regulation of heat generation (GO:0031650) | 3.14473128 |
| 43 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.13296681 |
| 44 | immunoglobulin mediated immune response (GO:0016064) | 3.12454532 |
| 45 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.09846797 |
| 46 | myeloid dendritic cell differentiation (GO:0043011) | 3.09105868 |
| 47 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.07166030 |
| 48 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.07086728 |
| 49 | macrophage activation (GO:0042116) | 3.06769265 |
| 50 | detection of bacterium (GO:0016045) | 3.05990952 |
| 51 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.05662147 |
| 52 | response to host immune response (GO:0052572) | 3.05321978 |
| 53 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.05321978 |
| 54 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.04828494 |
| 55 | myeloid dendritic cell activation (GO:0001773) | 3.03278194 |
| 56 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.03178916 |
| 57 | regulation of chemokine biosynthetic process (GO:0045073) | 3.02903393 |
| 58 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.02677478 |
| 59 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.02332624 |
| 60 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.00274145 |
| 61 | detection of external biotic stimulus (GO:0098581) | 2.97401418 |
| 62 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.95417121 |
| 63 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.95183296 |
| 64 | detection of biotic stimulus (GO:0009595) | 2.95105173 |
| 65 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.93286063 |
| 66 | T-helper 1 type immune response (GO:0042088) | 2.93284924 |
| 67 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.93272291 |
| 68 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.92691762 |
| 69 | regulation of interleukin-12 production (GO:0032655) | 2.92420069 |
| 70 | myeloid cell activation involved in immune response (GO:0002275) | 2.91534739 |
| 71 | regulation of gamma-delta T cell activation (GO:0046643) | 2.91529369 |
| 72 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.90977187 |
| 73 | response to host (GO:0075136) | 2.90977187 |
| 74 | response to host defenses (GO:0052200) | 2.90977187 |
| 75 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.90223247 |
| 76 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.89770592 |
| 77 | negative regulation of interleukin-1 production (GO:0032692) | 2.89624616 |
| 78 | positive regulation of antigen processing and presentation (GO:0002579) | 2.87699946 |
| 79 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.87011065 |
| 80 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.85630534 |
| 81 | positive regulation of humoral immune response (GO:0002922) | 2.83735360 |
| 82 | neutrophil mediated immunity (GO:0002446) | 2.83093599 |
| 83 | negative regulation of T cell mediated immunity (GO:0002710) | 2.81833543 |
| 84 | leukocyte cell-cell adhesion (GO:0007159) | 2.79640612 |
| 85 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.77592503 |
| 86 | B cell homeostasis (GO:0001782) | 2.77405882 |
| 87 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.77201621 |
| 88 | natural killer cell mediated immunity (GO:0002228) | 2.77201621 |
| 89 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.76909494 |
| 90 | cell adhesion mediated by integrin (GO:0033627) | 2.76094716 |
| 91 | defense response to protozoan (GO:0042832) | 2.76093148 |
| 92 | I-kappaB phosphorylation (GO:0007252) | 2.75347758 |
| 93 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.74710953 |
| 94 | negative regulation of cell killing (GO:0031342) | 2.74710953 |
| 95 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.74648737 |
| 96 | regulation of germinal center formation (GO:0002634) | 2.74585329 |
| 97 | positive regulation of type 2 immune response (GO:0002830) | 2.74498355 |
| 98 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.73790520 |
| 99 | T-helper cell differentiation (GO:0042093) | 2.73354581 |
| 100 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.73354581 |
| 101 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.72752970 |
| 102 | positive regulation of interferon-beta production (GO:0032728) | 2.72627778 |
| 103 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.70984825 |
| 104 | response to protozoan (GO:0001562) | 2.70973353 |
| 105 | negative regulation of interleukin-8 production (GO:0032717) | 2.70170734 |
| 106 | negative regulation of interleukin-6 production (GO:0032715) | 2.70034931 |
| 107 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.69905268 |
| 108 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.69905268 |
| 109 | regulation of vitamin metabolic process (GO:0030656) | 2.68097055 |
| 110 | monocyte chemotaxis (GO:0002548) | 2.68039656 |
| 111 | positive regulation of interleukin-2 production (GO:0032743) | 2.67991824 |
| 112 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.67215114 |
| 113 | respiratory burst (GO:0045730) | 2.66396437 |
| 114 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.66368337 |
| 115 | positive regulation of B cell differentiation (GO:0045579) | 2.66174025 |
| 116 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.65631940 |
| 117 | regulation of mast cell degranulation (GO:0043304) | 2.64243757 |
| 118 | positive regulation of p38MAPK cascade (GO:1900745) | 2.63960308 |
| 119 | T cell activation involved in immune response (GO:0002286) | 2.63731208 |
| 120 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.63130869 |
| 121 | myeloid leukocyte mediated immunity (GO:0002444) | 2.62291283 |
| 122 | positive thymic T cell selection (GO:0045059) | 2.62190444 |
| 123 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.61903260 |
| 124 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.61793356 |
| 125 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.61325206 |
| 126 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.61196400 |
| 127 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.60961537 |
| 128 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.60890782 |
| 129 | response to type I interferon (GO:0034340) | 2.60781466 |
| 130 | cellular response to type I interferon (GO:0071357) | 2.60755405 |
| 131 | type I interferon signaling pathway (GO:0060337) | 2.60755405 |
| 132 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.60730876 |
| 133 | regulation of interleukin-6 production (GO:0032675) | 2.60659325 |
| 134 | regulation of tolerance induction (GO:0002643) | 2.60539061 |
| 135 | regulation of podosome assembly (GO:0071801) | 2.60307025 |
| 136 | negative thymic T cell selection (GO:0045060) | 2.60169679 |
| 137 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.59650102 |
| 138 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.58545610 |
| 139 | B cell mediated immunity (GO:0019724) | 2.57083229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.43861628 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.93764683 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.68777865 |
| 4 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.66982178 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.14492765 |
| 6 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.74744319 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.65515563 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.54887212 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.53656847 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.34954993 |
| 11 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.28909341 |
| 12 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.20274638 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.19132520 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.12550725 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.96952368 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.79426920 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.72202911 |
| 18 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.58887797 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.42547850 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.33704380 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.28111248 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.27166468 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.11378043 |
| 24 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.02990198 |
| 25 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.95983477 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.94062721 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.91305116 |
| 28 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.81659378 |
| 29 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.80624880 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 1.79172834 |
| 31 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.73838337 |
| 32 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.72699582 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.71050735 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.68452071 |
| 35 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.65653212 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.64644758 |
| 37 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.63471789 |
| 38 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.61086952 |
| 39 | MAF_26560356_Chip-Seq_TH1_Human | 1.52871993 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.52860295 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.50442186 |
| 42 | * MYB_26560356_Chip-Seq_TH1_Human | 1.46630649 |
| 43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37593054 |
| 44 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.35015048 |
| 45 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.32677145 |
| 46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28740441 |
| 47 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.27998186 |
| 48 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.27434093 |
| 49 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.27434093 |
| 50 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26020794 |
| 51 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24809595 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.24459582 |
| 53 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23450332 |
| 54 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.22909460 |
| 55 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.18845848 |
| 56 | MYC_22102868_ChIP-Seq_BL_Human | 1.18631077 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18522264 |
| 58 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.16962167 |
| 59 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.14960725 |
| 60 | CJUN_26792858_Chip-Seq_BT549_Human | 1.14728850 |
| 61 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.14131008 |
| 62 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14079934 |
| 63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13688443 |
| 64 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.12321948 |
| 65 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.10710099 |
| 66 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10215298 |
| 67 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.09981171 |
| 68 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07950305 |
| 69 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07615972 |
| 70 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.06990298 |
| 71 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06848515 |
| 72 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05865073 |
| 73 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.03840588 |
| 74 | UTX_26944678_Chip-Seq_JUKART_Human | 1.03093085 |
| 75 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02400846 |
| 76 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02269027 |
| 77 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01094368 |
| 78 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99510622 |
| 79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98415351 |
| 80 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97848655 |
| 81 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.97721539 |
| 82 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.97267593 |
| 83 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.96703318 |
| 84 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95818642 |
| 85 | MAF_26560356_Chip-Seq_TH2_Human | 0.94636423 |
| 86 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94633451 |
| 87 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.93818434 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93352925 |
| 89 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.92602210 |
| 90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92266125 |
| 91 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.91475346 |
| 92 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.91455073 |
| 93 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.90253589 |
| 94 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90121730 |
| 95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.87676976 |
| 96 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87645605 |
| 97 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.87110748 |
| 98 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86997960 |
| 99 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85410158 |
| 100 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83973838 |
| 101 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83758622 |
| 102 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.82632740 |
| 103 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.81992362 |
| 104 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.81944734 |
| 105 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.81944734 |
| 106 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.81944734 |
| 107 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.81820404 |
| 108 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.81490724 |
| 109 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.80426697 |
| 110 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79993921 |
| 111 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79993921 |
| 112 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79023727 |
| 113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78934567 |
| 114 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78656091 |
| 115 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77470340 |
| 116 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.76963342 |
| 117 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.76586431 |
| 118 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.76536237 |
| 119 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.75410337 |
| 120 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.75402022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.80161984 |
| 2 | MP0009785_altered_susceptibility_to | 3.42474149 |
| 3 | MP0003436_decreased_susceptibility_to | 3.39051410 |
| 4 | MP0003303_peritoneal_inflammation | 3.34606392 |
| 5 | MP0003724_increased_susceptibility_to | 3.31104550 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.09101959 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 3.08213065 |
| 8 | MP0002419_abnormal_innate_immunity | 2.88282404 |
| 9 | MP0005671_abnormal_response_to | 2.80438213 |
| 10 | MP0005387_immune_system_phenotype | 2.73836656 |
| 11 | MP0001790_abnormal_immune_system | 2.73836656 |
| 12 | MP0000685_abnormal_immune_system | 2.65668248 |
| 13 | MP0006082_CNS_inflammation | 2.64597114 |
| 14 | * MP0001800_abnormal_humoral_immune | 2.61115213 |
| 15 | MP0005025_abnormal_response_to | 2.59528114 |
| 16 | * MP0002452_abnormal_antigen_presenting | 2.56390649 |
| 17 | MP0000569_abnormal_digit_pigmentation | 2.52602378 |
| 18 | MP0009278_abnormal_bone_marrow | 2.51256164 |
| 19 | * MP0002723_abnormal_immune_serum | 2.50254550 |
| 20 | MP0004510_myositis | 2.45178664 |
| 21 | * MP0004947_skin_inflammation | 2.30252533 |
| 22 | * MP0001819_abnormal_immune_cell | 2.17804387 |
| 23 | * MP0002420_abnormal_adaptive_immunity | 2.16558941 |
| 24 | MP0002405_respiratory_system_inflammati | 2.11323999 |
| 25 | MP0001853_heart_inflammation | 2.11279287 |
| 26 | MP0003300_gastrointestinal_ulcer | 2.10246973 |
| 27 | MP0002254_reproductive_system_inflammat | 2.02942532 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.99435659 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.94986164 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.93133652 |
| 31 | MP0008004_abnormal_stomach_pH | 1.86503928 |
| 32 | MP0002006_tumorigenesis | 1.86290998 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.81894550 |
| 34 | MP0003448_altered_tumor_morphology | 1.75327573 |
| 35 | MP0001545_abnormal_hematopoietic_system | 1.72658229 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.72658229 |
| 37 | MP0003763_abnormal_thymus_physiology | 1.66122027 |
| 38 | MP0009764_decreased_sensitivity_to | 1.65050755 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.62602745 |
| 40 | MP0005058_abnormal_lysosome_morphology | 1.61358895 |
| 41 | MP0001873_stomach_inflammation | 1.58839006 |
| 42 | MP0000716_abnormal_immune_system | 1.54409069 |
| 43 | MP0002933_joint_inflammation | 1.53191188 |
| 44 | MP0003453_abnormal_keratinocyte_physiol | 1.52212771 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.49194818 |
| 46 | MP0002398_abnormal_bone_marrow | 1.48826359 |
| 47 | MP0003828_pulmonary_edema | 1.44506415 |
| 48 | MP0005076_abnormal_cell_differentiation | 1.44201675 |
| 49 | MP0003656_abnormal_erythrocyte_physiolo | 1.43787634 |
| 50 | MP0008469_abnormal_protein_level | 1.42327115 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.41213506 |
| 52 | MP0000858_altered_metastatic_potential | 1.38888079 |
| 53 | MP0002138_abnormal_hepatobiliary_system | 1.37611204 |
| 54 | MP0005167_abnormal_blood-brain_barrier | 1.36932998 |
| 55 | MP0000343_altered_response_to | 1.36492450 |
| 56 | MP0003075_altered_response_to | 1.33163825 |
| 57 | MP0005310_abnormal_salivary_gland | 1.30864110 |
| 58 | MP0002277_abnormal_respiratory_mucosa | 1.30199769 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.27273237 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.25418282 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.23305383 |
| 62 | MP0002429_abnormal_blood_cell | 1.19067952 |
| 63 | MP0002722_abnormal_immune_system | 1.15973374 |
| 64 | * MP0001851_eye_inflammation | 1.14566819 |
| 65 | MP0003566_abnormal_cell_adhesion | 1.14524133 |
| 66 | MP0005390_skeleton_phenotype | 1.13626251 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.13438549 |
| 68 | MP0002332_abnormal_exercise_endurance | 1.11891095 |
| 69 | MP0010352_gastrointestinal_tract_polyps | 1.11287422 |
| 70 | MP0005174_abnormal_tail_pigmentation | 1.06405080 |
| 71 | MP0005164_abnormal_response_to | 1.04939466 |
| 72 | MP0008260_abnormal_autophagy | 1.03021042 |
| 73 | MP0005166_decreased_susceptibility_to | 1.02886244 |
| 74 | MP0002132_abnormal_respiratory_system | 1.01568423 |
| 75 | MP0003091_abnormal_cell_migration | 1.01404582 |
| 76 | MP0000249_abnormal_blood_vessel | 0.99544012 |
| 77 | MP0001501_abnormal_sleep_pattern | 0.99420972 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 0.99341369 |
| 79 | MP0003195_calcinosis | 0.98690900 |
| 80 | MP0005023_abnormal_wound_healing | 0.98632350 |
| 81 | MP0009763_increased_sensitivity_to | 0.94020341 |
| 82 | MP0004381_abnormal_hair_follicle | 0.90513676 |
| 83 | MP0002139_abnormal_hepatobiliary_system | 0.89218146 |
| 84 | MP0004808_abnormal_hematopoietic_stem | 0.89053667 |
| 85 | MP0009840_abnormal_foam_cell | 0.88965359 |
| 86 | MP0002877_abnormal_melanocyte_morpholog | 0.88188869 |
| 87 | MP0003866_abnormal_defecation | 0.86326781 |
| 88 | MP0000703_abnormal_thymus_morphology | 0.85176174 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.85063280 |
| 90 | MP0006054_spinal_hemorrhage | 0.82647391 |
| 91 | MP0001243_abnormal_dermal_layer | 0.79418846 |
| 92 | MP0004883_abnormal_blood_vessel | 0.79407298 |
| 93 | MP0003795_abnormal_bone_structure | 0.78942789 |
| 94 | MP0003045_fibrosis | 0.78788993 |
| 95 | MP0001663_abnormal_digestive_system | 0.78089445 |
| 96 | MP0000767_abnormal_smooth_muscle | 0.76966841 |
| 97 | MP0004484_altered_response_of | 0.75818998 |
| 98 | MP0004782_abnormal_surfactant_physiolog | 0.75643912 |
| 99 | MP0000383_abnormal_hair_follicle | 0.74791932 |
| 100 | MP0000604_amyloidosis | 0.74787312 |
| 101 | MP0000371_diluted_coat_color | 0.74766780 |
| 102 | MP0002009_preneoplasia | 0.72568858 |
| 103 | MP0005451_abnormal_body_composition | 0.72540135 |
| 104 | MP0000015_abnormal_ear_pigmentation | 0.71533763 |
| 105 | MP0001879_abnormal_lymphatic_vessel | 0.71390531 |
| 106 | MP0001958_emphysema | 0.70649608 |
| 107 | MP0005165_increased_susceptibility_to | 0.70020305 |
| 108 | MP0005257_abnormal_intraocular_pressure | 0.68523838 |
| 109 | * MP0001216_abnormal_epidermal_layer | 0.68409119 |
| 110 | MP0001542_abnormal_bone_strength | 0.68102197 |
| 111 | * MP0001191_abnormal_skin_condition | 0.67445669 |
| 112 | MP0003690_abnormal_glial_cell | 0.67420526 |
| 113 | MP0002396_abnormal_hematopoietic_system | 0.66404379 |
| 114 | MP0010307_abnormal_tumor_latency | 0.66311745 |
| 115 | MP0003950_abnormal_plasma_membrane | 0.66025267 |
| 116 | MP0003252_abnormal_bile_duct | 0.65634626 |
| 117 | MP0002136_abnormal_kidney_physiology | 0.61803396 |
| 118 | MP0005535_abnormal_body_temperature | 0.60532247 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.99180494 |
| 2 | Stomatitis (HP:0010280) | 5.73404101 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.69978246 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.67136125 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.63863425 |
| 6 | Optic neuritis (HP:0100653) | 5.39110303 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 5.39110303 |
| 8 | Orchitis (HP:0100796) | 5.27859397 |
| 9 | Myositis (HP:0100614) | 4.98835697 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.42493945 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.93977298 |
| 12 | Vasculitis (HP:0002633) | 3.89715809 |
| 13 | Thick nail (HP:0001805) | 3.82344740 |
| 14 | Prostate neoplasm (HP:0100787) | 3.75003187 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.73467114 |
| 16 | Pulmonary infiltrates (HP:0002113) | 3.70619845 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.56505567 |
| 18 | Hematochezia (HP:0002573) | 3.52215347 |
| 19 | Gingivitis (HP:0000230) | 3.51951226 |
| 20 | Recurrent skin infections (HP:0001581) | 3.48258131 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.46046048 |
| 22 | Keratoconjunctivitis sicca (HP:0001097) | 3.34136378 |
| 23 | Pustule (HP:0200039) | 3.32712387 |
| 24 | Arterial thrombosis (HP:0004420) | 3.17684146 |
| 25 | Periodontitis (HP:0000704) | 3.15876107 |
| 26 | Autoimmune hemolytic anemia (HP:0001890) | 3.14268982 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 3.08601519 |
| 28 | Systemic lupus erythematosus (HP:0002725) | 3.07496213 |
| 29 | Leukocytosis (HP:0001974) | 3.06769398 |
| 30 | Keratoconjunctivitis (HP:0001096) | 3.05413084 |
| 31 | Increased IgE level (HP:0003212) | 3.03785460 |
| 32 | Obstructive lung disease (HP:0006536) | 3.00000734 |
| 33 | Chronic obstructive pulmonary disease (HP:0006510) | 3.00000734 |
| 34 | Hemoptysis (HP:0002105) | 2.90504674 |
| 35 | Recurrent viral infections (HP:0004429) | 2.76386250 |
| 36 | Amyloidosis (HP:0011034) | 2.74587537 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 2.73786431 |
| 38 | Alveolar cell carcinoma (HP:0006519) | 2.71108780 |
| 39 | Abnormality of the prostate (HP:0008775) | 2.67222925 |
| 40 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.64129824 |
| 41 | Myocardial infarction (HP:0001658) | 2.61427216 |
| 42 | Gastrointestinal infarctions (HP:0005244) | 2.58059513 |
| 43 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.57937310 |
| 44 | Meningitis (HP:0001287) | 2.56593506 |
| 45 | Premature loss of primary teeth (HP:0006323) | 2.55960701 |
| 46 | Increased cerebral lipofuscin (HP:0011813) | 2.55797065 |
| 47 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.51593007 |
| 48 | Recurrent cutaneous fungal infections (HP:0011370) | 2.51593007 |
| 49 | Increased IgM level (HP:0003496) | 2.51299660 |
| 50 | Glomerulonephritis (HP:0000099) | 2.50879639 |
| 51 | Osteomyelitis (HP:0002754) | 2.46334021 |
| 52 | Cellulitis (HP:0100658) | 2.42914949 |
| 53 | Abnormality of T cells (HP:0002843) | 2.42164337 |
| 54 | Gingival bleeding (HP:0000225) | 2.41714344 |
| 55 | Interstitial pulmonary disease (HP:0006530) | 2.39577712 |
| 56 | Joint swelling (HP:0001386) | 2.39510954 |
| 57 | Spontaneous hematomas (HP:0007420) | 2.39372831 |
| 58 | Gangrene (HP:0100758) | 2.38474384 |
| 59 | Colitis (HP:0002583) | 2.37498237 |
| 60 | Recurrent bronchitis (HP:0002837) | 2.35909747 |
| 61 | Dysostosis multiplex (HP:0000943) | 2.34236836 |
| 62 | Eosinophilia (HP:0001880) | 2.33361836 |
| 63 | Osteolytic defects of the hand bones (HP:0009699) | 2.32369623 |
| 64 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.32369623 |
| 65 | Urticaria (HP:0001025) | 2.31360348 |
| 66 | Spondylolisthesis (HP:0003302) | 2.30906675 |
| 67 | Abnormality of T cell physiology (HP:0011840) | 2.30795867 |
| 68 | Anhidrosis (HP:0000970) | 2.25529829 |
| 69 | Stomach cancer (HP:0012126) | 2.24293303 |
| 70 | Chronic diarrhea (HP:0002028) | 2.23944755 |
| 71 | Agammaglobulinemia (HP:0004432) | 2.23693742 |
| 72 | Abnormality of the pericardium (HP:0001697) | 2.22070112 |
| 73 | Inflammation of the large intestine (HP:0002037) | 2.18430443 |
| 74 | Abnormality of the nasal septum (HP:0000419) | 2.17919852 |
| 75 | Tetraparesis (HP:0002273) | 2.16758455 |
| 76 | Submucous cleft hard palate (HP:0000176) | 2.16492521 |
| 77 | Abnormality of T cell number (HP:0011839) | 2.16266856 |
| 78 | Panhypogammaglobulinemia (HP:0003139) | 2.16255326 |
| 79 | Persistence of primary teeth (HP:0006335) | 2.13145214 |
| 80 | Anorexia (HP:0002039) | 2.12339148 |
| 81 | Recurrent pneumonia (HP:0006532) | 2.12111169 |
| 82 | Pulmonary embolism (HP:0002204) | 2.11300039 |
| 83 | Abnormality of glycolipid metabolism (HP:0010969) | 2.11128600 |
| 84 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.11128600 |
| 85 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.11128600 |
| 86 | Epistaxis (HP:0000421) | 2.09994112 |
| 87 | Axonal loss (HP:0003447) | 2.09808584 |
| 88 | Viral hepatitis (HP:0006562) | 2.09401258 |
| 89 | Petechiae (HP:0000967) | 2.09083503 |
| 90 | Malnutrition (HP:0004395) | 2.08970040 |
| 91 | Abnormality of eosinophils (HP:0001879) | 2.05231740 |
| 92 | T lymphocytopenia (HP:0005403) | 2.04281764 |
| 93 | Fatigue (HP:0012378) | 2.03521653 |
| 94 | Loss of speech (HP:0002371) | 2.03383452 |
| 95 | Bone pain (HP:0002653) | 2.02840327 |
| 96 | Abnormality of the pleura (HP:0002103) | 2.01411046 |
| 97 | Arthralgia (HP:0002829) | 2.01142966 |
| 98 | Restrictive lung disease (HP:0002091) | 2.01124724 |
| 99 | Basal ganglia calcification (HP:0002135) | 2.00499512 |
| 100 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.00380614 |
| 101 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.00380614 |
| 102 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.00380614 |
| 103 | Mucopolysacchariduria (HP:0008155) | 1.99206612 |
| 104 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.99206612 |
| 105 | Slow saccadic eye movements (HP:0000514) | 1.98904025 |
| 106 | Pulmonary artery stenosis (HP:0004415) | 1.98867146 |
| 107 | Thyroiditis (HP:0100646) | 1.97719486 |
| 108 | Polyneuropathy (HP:0001271) | 1.97153737 |
| 109 | Increased CSF protein (HP:0002922) | 1.97037171 |
| 110 | Gastrointestinal inflammation (HP:0004386) | 1.96880712 |
| 111 | Increased serum ferritin (HP:0003281) | 1.96032845 |
| 112 | Glomerulopathy (HP:0100820) | 1.94702142 |
| 113 | Urethral obstruction (HP:0000796) | 1.90870043 |
| 114 | Episodic fever (HP:0001954) | 1.89078722 |
| 115 | Chest pain (HP:0100749) | 1.87200549 |
| 116 | Vertebral compression fractures (HP:0002953) | 1.86609103 |
| 117 | Hypergammaglobulinemia (HP:0010702) | 1.85565720 |
| 118 | Granulocytopenia (HP:0001913) | 1.85359378 |
| 119 | Gastrointestinal stroma tumor (HP:0100723) | 1.85332105 |
| 120 | Skin ulcer (HP:0200042) | 1.83733762 |
| 121 | Keratitis (HP:0000491) | 1.83085791 |
| 122 | Abnormality of the fingertips (HP:0001211) | 1.79676830 |
| 123 | Prolonged bleeding time (HP:0003010) | 1.78102950 |
| 124 | Encephalitis (HP:0002383) | 1.77809684 |
| 125 | Nephritis (HP:0000123) | 1.77709801 |
| 126 | IgA deficiency (HP:0002720) | 1.74393590 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.37202222 |
| 2 | TXK | 4.03485474 |
| 3 | IRAK3 | 3.88767671 |
| 4 | TBK1 | 3.29026648 |
| 5 | IKBKE | 2.94771463 |
| 6 | IKBKB | 2.85788793 |
| 7 | IRAK4 | 2.77399221 |
| 8 | RIPK4 | 2.74454216 |
| 9 | TYK2 | 2.73435680 |
| 10 | MAP4K1 | 2.47369134 |
| 11 | JAK3 | 2.25451886 |
| 12 | BLK | 2.24046319 |
| 13 | TGFBR2 | 2.22440090 |
| 14 | CHUK | 2.15935761 |
| 15 | JAK1 | 2.03257415 |
| 16 | PRPF4B | 2.00207791 |
| 17 | TAOK3 | 1.90538760 |
| 18 | MAP3K13 | 1.67671838 |
| 19 | STK10 | 1.59535838 |
| 20 | MAPK15 | 1.54858662 |
| 21 | BMPR2 | 1.53285496 |
| 22 | ZAP70 | 1.52541256 |
| 23 | EPHB1 | 1.50393654 |
| 24 | ITK | 1.47514394 |
| 25 | TEC | 1.39438439 |
| 26 | KIT | 1.38965912 |
| 27 | CSK | 1.37486670 |
| 28 | GRK6 | 1.37455249 |
| 29 | ERN1 | 1.34322026 |
| 30 | NEK9 | 1.28882307 |
| 31 | MAP3K3 | 1.26266571 |
| 32 | HCK | 1.21979369 |
| 33 | MST4 | 1.19686620 |
| 34 | PIM2 | 1.14689858 |
| 35 | JAK2 | 1.12698217 |
| 36 | RPS6KA4 | 1.12291680 |
| 37 | PIM1 | 1.12057334 |
| 38 | LCK | 1.11327296 |
| 39 | EIF2AK2 | 1.10118563 |
| 40 | RIPK1 | 1.09451931 |
| 41 | BTK | 1.09271920 |
| 42 | PDK2 | 1.02151692 |
| 43 | EPHA3 | 1.01902274 |
| 44 | MAP3K10 | 0.99870037 |
| 45 | MARK3 | 0.98722964 |
| 46 | AKT3 | 0.97751388 |
| 47 | FGFR3 | 0.96166784 |
| 48 | SYK | 0.95740702 |
| 49 | PIK3CG | 0.91271522 |
| 50 | PTK6 | 0.89801393 |
| 51 | CDC42BPA | 0.88797630 |
| 52 | GRK7 | 0.87965996 |
| 53 | CSF1R | 0.86738227 |
| 54 | TAOK2 | 0.86110672 |
| 55 | IRAK1 | 0.85388822 |
| 56 | SIK3 | 0.85230470 |
| 57 | TRPM7 | 0.83541133 |
| 58 | TNK2 | 0.82875578 |
| 59 | LYN | 0.79015363 |
| 60 | MAP2K3 | 0.78674732 |
| 61 | CDK12 | 0.78305226 |
| 62 | FGFR4 | 0.75978470 |
| 63 | TAOK1 | 0.74295126 |
| 64 | MAP3K6 | 0.72097812 |
| 65 | NLK | 0.70799465 |
| 66 | PDK1 | 0.70344413 |
| 67 | FGR | 0.69687204 |
| 68 | PDGFRB | 0.64270533 |
| 69 | MAP3K11 | 0.63575102 |
| 70 | MST1R | 0.61451809 |
| 71 | MAP3K2 | 0.61249930 |
| 72 | SIK2 | 0.60634491 |
| 73 | MAPKAPK2 | 0.60118976 |
| 74 | FES | 0.60063427 |
| 75 | NUAK1 | 0.58088714 |
| 76 | MOS | 0.58063319 |
| 77 | ABL1 | 0.56470537 |
| 78 | BMX | 0.56394074 |
| 79 | GSK3A | 0.55050296 |
| 80 | MAP3K7 | 0.53985211 |
| 81 | FRK | 0.53895166 |
| 82 | MAP2K2 | 0.53551701 |
| 83 | MATK | 0.53531987 |
| 84 | MARK2 | 0.53395077 |
| 85 | MAPK7 | 0.53043054 |
| 86 | EGFR | 0.51553378 |
| 87 | CDK6 | 0.51396026 |
| 88 | CLK1 | 0.49940880 |
| 89 | PRKCQ | 0.48966779 |
| 90 | TTN | 0.48536118 |
| 91 | BRD4 | 0.48510889 |
| 92 | IRAK2 | 0.48333677 |
| 93 | PDPK1 | 0.47547781 |
| 94 | PIK3CA | 0.43711209 |
| 95 | SGK3 | 0.43218514 |
| 96 | HIPK2 | 0.41609586 |
| 97 | RPS6KL1 | 0.41559774 |
| 98 | RPS6KC1 | 0.41559774 |
| 99 | CAMKK2 | 0.41065251 |
| 100 | ERBB3 | 0.39553234 |
| 101 | NEK6 | 0.39209568 |
| 102 | SGK2 | 0.38745561 |
| 103 | YES1 | 0.38107734 |
| 104 | PRKCD | 0.37971314 |
| 105 | MELK | 0.37772579 |
| 106 | TIE1 | 0.36749155 |
| 107 | CDK9 | 0.36600363 |
| 108 | PRKD2 | 0.36151325 |
| 109 | FLT3 | 0.35981542 |
| 110 | MAP2K6 | 0.35462285 |
| 111 | PTK2B | 0.35233111 |
| 112 | STK3 | 0.34954055 |
| 113 | INSR | 0.34676459 |
| 114 | IGF1R | 0.33918050 |
| 115 | RPS6KA6 | 0.32082048 |
| 116 | PBK | 0.31895470 |
| 117 | MAP3K1 | 0.31788009 |
| 118 | MAP3K5 | 0.29191540 |
| 119 | RPS6KA5 | 0.26774409 |
| 120 | RPS6KA1 | 0.25275346 |
| 121 | PKN1 | 0.25213360 |
| 122 | MAPK12 | 0.24659089 |
| 123 | MAPK4 | 0.23591064 |
| 124 | MAPK3 | 0.23006281 |
| 125 | STK24 | 0.22695546 |
| 126 | LRRK2 | 0.22247384 |
| 127 | PRKG2 | 0.22068374 |
| 128 | DMPK | 0.21997028 |
| 129 | KDR | 0.21377358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.17308495 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.97895435 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.88404587 |
| 4 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.84658000 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.77045785 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.73649746 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.61109982 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.43139073 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.38269588 |
| 10 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.33391664 |
| 11 | Malaria_Homo sapiens_hsa05144 | 2.31537254 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 2.29767576 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 2.16884766 |
| 14 | Measles_Homo sapiens_hsa05162 | 2.05486098 |
| 15 | Asthma_Homo sapiens_hsa05310 | 2.05449860 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.95087712 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.91761287 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.88815749 |
| 19 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.85307614 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.79347916 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.78597609 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.75526396 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.74290135 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.73800745 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.70509072 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.65945450 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.59235390 |
| 28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.54388929 |
| 29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.52864756 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.50454897 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.44598135 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.43686320 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.37440007 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32692996 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.31552409 |
| 36 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.25378004 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22711073 |
| 38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.21810895 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.20493869 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.15151399 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.13054330 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.07853201 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02868369 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00899428 |
| 45 | Amoebiasis_Homo sapiens_hsa05146 | 0.99545760 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 0.98579871 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96407744 |
| 48 | Phagosome_Homo sapiens_hsa04145 | 0.94924446 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.91315787 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89632308 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87142148 |
| 52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87053682 |
| 53 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.83132468 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80607270 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.79845712 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79759508 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70291047 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70137266 |
| 59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67363203 |
| 60 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67143219 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.67088411 |
| 62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67025445 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66132174 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.64252580 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64144097 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60202104 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57825669 |
| 68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56654880 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.54313921 |
| 70 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.52123358 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50748177 |
| 72 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.50542837 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.49241339 |
| 74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49026838 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48562134 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48107925 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47742428 |
| 78 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47223057 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46023737 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.45708065 |
| 81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45033293 |
| 82 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.44820798 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44381723 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43913776 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42911470 |
| 86 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.42794901 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | 0.41441380 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41351935 |
| 89 | Prostate cancer_Homo sapiens_hsa05215 | 0.41141691 |
| 90 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39429328 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38412347 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38253360 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36912165 |
| 94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36384879 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.36164024 |
| 96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35604110 |
| 97 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33339505 |
| 98 | Focal adhesion_Homo sapiens_hsa04510 | 0.32258220 |
| 99 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.31434127 |
| 100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.29820180 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29146015 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28790330 |
| 103 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.27623740 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27525267 |
| 105 | Adherens junction_Homo sapiens_hsa04520 | 0.27251417 |
| 106 | Mineral absorption_Homo sapiens_hsa04978 | 0.27112681 |
| 107 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25281397 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.23815285 |
| 109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23198620 |
| 110 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.22966654 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.22918665 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.22117079 |
| 113 | Pathways in cancer_Homo sapiens_hsa05200 | 0.21431364 |
| 114 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21033800 |
| 115 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.20633485 |

